Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

BUY
$24.32 - $75.3 $60,240 - $186,518
2,477 Added 21.71%
13,887 $1.05 Million
Q1 2022

May 11, 2022

BUY
$24.73 - $51.25 $45,725 - $94,761
1,849 Added 19.34%
11,410 $306,000
Q4 2021

Feb 10, 2022

SELL
$35.48 - $67.33 $33,102 - $62,818
-933 Reduced 8.89%
9,561 $456,000
Q3 2021

Oct 28, 2021

BUY
$61.0 - $81.99 $105,957 - $142,416
1,737 Added 19.84%
10,494 $697,000
Q2 2021

Aug 10, 2021

SELL
$62.93 - $90.59 $42,603 - $61,329
-677 Reduced 7.18%
8,757 $683,000
Q1 2021

Jul 21, 2021

SELL
$88.19 - $140.01 $117,645 - $186,773
-1,334 Reduced 12.39%
9,434 $892,000
Q4 2020

Feb 12, 2021

SELL
$87.69 - $130.94 $2.42 Million - $3.61 Million
-27,586 Reduced 71.92%
10,768 $1.31 Million
Q3 2020

Oct 30, 2020

BUY
$56.99 - $89.33 $2.19 Million - $3.43 Million
38,354 New
38,354 $3.35 Million

About Turning Point Therapeutics, Inc.


  • Ticker TPTX
  • Exchange NASDAQ
  • Shares Outstandng 50,074,300
More about TPTX
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.